RDY
Dr. Reddy'S Laboratories
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
RDY Profile
Dr. Reddy'S Laboratories Limited
An Indian developer of active pharmaceutical ingredients, intermediates, and finished dosage forms
Pharmaceutical
02/24/1984
04/11/2001
New York Stock Exchange
27,811
03-31
Depository Receipts (Ordinary Shares)
8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India
--
Dr. Reddy'S Laboratories Limited, established on February 24, 1984, is an integrated global pharmaceutical company dedicated to providing new drugs at affordable prices through its three core business divisions: Global Generics Division, Pharmaceutical Services and Active Ingredients Division (PSAI) and Proprietary Products Division. Its global branded and unbranded generic drug segment includes prescription and over-the-counter (OTC) drug operations. The company's Pharmaceutical Services and Active Ingredients Division (PSAI) consists of the Pharmaceutical Ingredients (API) business and customized pharmaceutical services. The company's patented product section consists of biopharmaceutical companies, new chemical entity business, differentiated formulation business and dermatological professional business key enterprises operated by promius pharmaceutical company.